"
Template:SupbiotechparisFr
From 2009.igem.org
(Difference between revisions)
Enguerrand (Talk | contribs) |
Enguerrand (Talk | contribs) |
||
| Line 57: | Line 57: | ||
<div id="menufond"> | <div id="menufond"> | ||
</div> | </div> | ||
| - | <div id="menu" | + | <div id="menu" style="margin-bottom: 40px; margin-top: 315px; background: transparent;"> |
| - | + | ||
<span style="color: black;"> '''Projet''' </span> | <span style="color: black;"> '''Projet''' </span> | ||
| + | |||
<span style="color: black;">'''Introduction'''</span> | <span style="color: black;">'''Introduction'''</span> | ||
[[Team:SupBiotech-Paris/Thérapies actuelles|Thérapies actuelles]] | [[Team:SupBiotech-Paris/Thérapies actuelles|Thérapies actuelles]] | ||
| Line 185: | Line 185: | ||
</body> | </body> | ||
</html> | </html> | ||
| - | |||
</div> | </div> | ||
| + | |||
{| | {| | ||
|- | |- | ||
|} | |} | ||
| - | <div style="margin-bottom: 320px;"></div> | + | <div style="margin-bottom: 320px;"> |
| + | </div> | ||
Revision as of 12:32, 3 September 2009
Projet
Introduction Thérapies actuelles Thérapies géniques 1er Constat Introduction Concept Conclusion 2nd Constat Introduction Concept Conclusion Mise en application Ciblage Tissulaire Ciblage Cellulaire Modification protéique Conclusion
Ressources
Biobricks
Matériel & Méthode
Bibliographie
Ethique & sûreté
Biologie Synthetique
Notre projet
Sûreté
|
|
